New York Office of Cannabis Management and Montefiore Einstein Open Registration for 3rd Annual Cannabinoids in Clinical Practice and Research Symposium

The New York State Office of Cannabis Management (OCM) and Albert Einstein College of Medicine-Montefiore Medical Center have announced that registration is now open for the third annual Cannabinoids in Clinical Practice and Research Symposium.

The two-day event will take place November 19 and 20 at the Westchester Marriott in Tarrytown, bringing together researchers, healthcare practitioners, public health professionals and trainees to discuss cannabis science, clinical care, public health, health equity and harm reduction.

“New York has become a national model for this work, bringing together thought leaders who are helping shape the future of cannabis research and clinical care not only here at home, but globally,” said OCM Executive Director John Kagia.

Programming begins November 19 with a free, two-hour New York State Medical Cannabis Program Practitioner Course. The course is open to practitioners licensed, registered or certified by New York State to prescribe controlled substances, as well as healthcare professionals seeking additional education on cannabis science and medicine.

Practitioners who complete the required course can become eligible to certify patients for New York’s Medical Cannabis Program. Attendees can register for the course separately at no cost or participate as part of the full symposium. Continuing education credit will be available for eligible healthcare professionals.

The first day will conclude with a fireside chat and reception focused on the current and future landscape of cannabis research and clinical practice.

On November 20, the full-day symposium will include keynote addresses, panel discussions and concurrent sessions covering three primary areas: cannabis in clinical practice, cannabis science, and cannabis public health, health equity and harm reduction.

Topics are expected to include evidence-based clinical applications, emerging research into therapeutic potential, cannabis use disorder, harm reduction and cannabis-related emergency department visits.

“Clinicians are increasingly encountering patients who use cannabis or have questions about its potential therapeutic benefits, risks, and interactions,” said Dr. June Chin, OCM’s chief medical officer. “Bringing researchers and healthcare professionals together allows us to examine the evidence, identify where knowledge gaps remain, and give practitioners evidence they can apply when counseling and caring for patients.”

Full symposium registration costs $350, with reduced rates of $200 for partner employees and faculty, $150 for residents and fellows, and $100 for graduate and medical students.

The symposium will be held at the Westchester Marriott, 670 White Plains Road in Tarrytown.